Cissampelos pareira L. extracts demonstrate anti-SARS-CoV-2 activity in vitro
A team of scientists from India has recently investigated the antiviral potency of a traditional medicinal plant Cissampelos pareira L.
Read more
Clonally expanded plasma cell lineages in SARS-CoV-2 produce specific neutralizing antibodies
The immune response to infection by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the cause of the ongoing coronavirus
Read more
Second dose of Pfizer-BioNTech COVID-19 vaccine may not benefit previously infected individuals
Researchers at the NYU Grossman School of Medicine have shown that a second dose of the Pfizer-BioNTech BNT162b2 vaccine may
Read more
Zinc supplementation bolsters repurposed antivirals against SARS-CoV-2
Since the beginning of the coronavirus disease 2019 (COVID-19) pandemic, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
Read more
Corona-insights from Italy: “That was the point where we were nervous,”
Maurizio Cecconi is an Italian intensive care physician and Director of the “Covid-19 Lombardy ICU Network”. Together with his colleagues,
Read more
AJR: Novel coronavirus (COVID-19) imaging features overlap with SARS and MERS
Although the imaging features of novel coronavirus disease 2019 (COVID-19) are variable and nonspecific, the findings reported thus far do
Read more